Hiromichi Hamada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hiromichi Hamada has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Takafumi Honda
Department of Pediatrics Tokyo Women's Medical University Yachiyo Medical Center Chiba Japan
5 shared publicationsMasaru Terai
Department of Pediatrics Tokyo Women's Medical University Yachiyo Medical Center Chiba Japan
4 shared publications- Masaru Terai
Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo-shi, Chiba, Japan
4 shared publications Ayako Muto
Department of Pediatrics Tokyo Women's Medical University Yachiyo Medical Center Chiba Japan
2 shared publicationsKitami Hayashi
Department of Pediatrics Tokyo Women's Medical University Yachiyo Medical Center Chiba Japan
2 shared publicationsKumi Yasukawa
Department of Pediatrics, Chiba University School of Medicine, Chiba, Japan
2 shared publications
Latest Publications
- 5 March 2014
- Published by Wiley in Microbiology and Immunology
- Vol. 58 (3) , 215-218
Characteristic systemic cytokine responses in children with human bocavirus‐positive lower respiratory tract infection
- 5 March 2014
- Published by Wiley in Microbiology and Immunology
- Vol. 58 (3) , 215-218
Characteristic systemic cytokine responses in children with human bocavirus‐positive lower respiratory tract infection
- Open Access
- 31 May 2013
- Published by Wiley in Pediatrics International
- Vol. 55 (4) , 536-537
WU polyomavirus detected in respiratory tract specimens from young children in Japan
Polyomaviruses (PyV) WU and KI are reportedly associated with respiratory tract disease (RTD) worldwide but their incidence is unclear in Japan. In a 2 year prospective study, WU/KIPyV were detected in 48 (13.9%) and in five (1.4%) of 345 children hospitalized with lower RTD, respectively. The seasonal distribution was observed in spring and early summer. Other respiratory viruses were co‐detected in 51% of PyV‐positive patients, but eight (2.3%) of the WUPyV‐positive patients were negative for other known pathogens.
- 31 May 2013
- Published by Wiley in Pediatrics International
- Vol. 55 (4) , 536-537
Open AccessWU polyomavirus detected in respiratory tract specimens from young children in Japan
Polyomaviruses (PyV) WU and KI are reportedly associated with respiratory tract disease (RTD) worldwide but their incidence is unclear in Japan. In a 2 year prospective study, WU/KIPyV were detected in 48 (13.9%) and in five (1.4%) of 345 children hospitalized with lower RTD, respectively. The seasonal distribution was observed in spring and early summer. Other respiratory viruses were co‐detected in 51% of PyV‐positive patients, but eight (2.3%) of the WUPyV‐positive patients were negative for other known pathogens.
- Open Access
- 10 April 2010
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 169 (9) , 1087-1092
Distinctive clinical features of human bocavirus in children younger than 2 years
Background and objective Clinical characteristics of human bocavirus (HBoV) infection have been studied worldwide, but their importance of those characteristics remains unknown. We investigated distinctive clinical features of HBoV-positive children with lower respiratory tract infection (LRTI). Methods and results During April 2007–July 2009, for 402 hospitalized children younger than 2 years with LRTI, we prospectively examined virus genomes in nasopharyngeal swabs for HBoV, respiratory syncytial virus (RSV), rhinovirus, metapneumovirus, parainfluenzavirus, and adenovirus. The HBoV genomes were identified in 34 patients (8.5%). Clinical and laboratory data of HBoV-positive and other virus/bacteria-negative patients (n = 18) were analyzed and compared with data of RSV-single positive patients (n = 99). The seasonal distribution of HBoV exhibits a concentration of cases during March–September, with most RSV cases occurring during winter in Japan. The minimum age of HBoV-positive patients was 5 months, although 44 patients (44%) with RSV were younger than 6 months. The main clinical features were respiratory distress and hypoxia. Hypoxia advances within 3 days after onset. The mean oxygen saturation on arrival was 92.8%, which was significantly lower than that in patients with RSV (p < 0.001). White blood cell counts were similar among groups. However, the percentage of neutrophils in white blood cells were significantly higher in HBoV-positive patients (62 vs. 45%, p < 0.001). Their prognoses were good. Their hospital stays were 6.6 days. Conclusions HBoV-single positive patients show several clinical characteristics, such as seasonality, age, hypoxia, and neutrophilia, which differ from those with RSV infection.
- 10 April 2010
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 169 (9) , 1087-1092
Open AccessDistinctive clinical features of human bocavirus in children younger than 2 years
Background and objective Clinical characteristics of human bocavirus (HBoV) infection have been studied worldwide, but their importance of those characteristics remains unknown. We investigated distinctive clinical features of HBoV-positive children with lower respiratory tract infection (LRTI). Methods and results During April 2007–July 2009, for 402 hospitalized children younger than 2 years with LRTI, we prospectively examined virus genomes in nasopharyngeal swabs for HBoV, respiratory syncytial virus (RSV), rhinovirus, metapneumovirus, parainfluenzavirus, and adenovirus. The HBoV genomes were identified in 34 patients (8.5%). Clinical and laboratory data of HBoV-positive and other virus/bacteria-negative patients (n = 18) were analyzed and compared with data of RSV-single positive patients (n = 99). The seasonal distribution of HBoV exhibits a concentration of cases during March–September, with most RSV cases occurring during winter in Japan. The minimum age of HBoV-positive patients was 5 months, although 44 patients (44%) with RSV were younger than 6 months. The main clinical features were respiratory distress and hypoxia. Hypoxia advances within 3 days after onset. The mean oxygen saturation on arrival was 92.8%, which was significantly lower than that in patients with RSV (p < 0.001). White blood cell counts were similar among groups. However, the percentage of neutrophils in white blood cells were significantly higher in HBoV-positive patients (62 vs. 45%, p < 0.001). Their prognoses were good. Their hospital stays were 6.6 days. Conclusions HBoV-single positive patients show several clinical characteristics, such as seasonality, age, hypoxia, and neutrophilia, which differ from those with RSV infection.
- 1 February 2008
- Vol. 66 (2) , 360-4
[Treatment for Kawasaki disease--perspective].
In acute management for Kawasaki disease, recent studies are focused on treatment for patients who failed to respond to intravenous gamma globulin (IVGG) and high dose-aspirin. The addition of corticosteroids to IVGG and the use of TNF-alpha blockade are now under discussion. In long-term management, therapeutic angiogenesis is now applied for adult patients with ischemic hind limb or heart. It could be one of the therapeutic options for children and adolescents with Kawasaki disease and coronary artery abnormalities.
- 1 February 2008
- Vol. 66 (2) , 360-4
[Treatment for Kawasaki disease--perspective].
In acute management for Kawasaki disease, recent studies are focused on treatment for patients who failed to respond to intravenous gamma globulin (IVGG) and high dose-aspirin. The addition of corticosteroids to IVGG and the use of TNF-alpha blockade are now under discussion. In long-term management, therapeutic angiogenesis is now applied for adult patients with ischemic hind limb or heart. It could be one of the therapeutic options for children and adolescents with Kawasaki disease and coronary artery abnormalities.
- 28 June 2006
- p. 46-8
[DiGeorge syndrome].
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 182
Effects of Intravenous Gammmaglobulin Therapy Combined with Dexamethasone for the Initial Treatment of Acute Kawasaki Disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 182
Effects of Intravenous Gammmaglobulin Therapy Combined with Dexamethasone for the Initial Treatment of Acute Kawasaki Disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 162
Mid-term Results of Heparin and Exercise Therapy for Patients with Myocardial Ischemia after Kawasaki Disease
- 1 January 2003
- Published by Springer Nature in Pediatric Research
- Vol. 53 (1) , 162
Mid-term Results of Heparin and Exercise Therapy for Patients with Myocardial Ischemia after Kawasaki Disease